Australia's Memphasys surges on regulatory nod for reproductive technology

Memphasys

09/02/2026 24:15

** Shares of Memphasys MEM.AX rise as much as 33.3% to A$0.008 in early trade, hitting their highest since February 3

** Stock logs largest intraday pct gain since February 2

** Assisted reproductive tech firm secures regulatory approval from Australia's Therapeutic Goods Association for its Felix tech system

** Felix is a bioseparation system that isolates the most viable sperm cells for human-assisted reproduction

** More than 16 million shares change hands, 2 times the 30-day average volume

** Stock flat YTD, including the day's moves

 (Reporting by Nikita Maria Jino in Bengaluru)

 ((Nikita.Jino@thomsonreuters.com;))